Valproic acid enhances protein l-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway

Neuropharmacology

Volumn 56, Issue 5, 2009, Pages 839-848

  Cournoyer, Philippe ^a   Desrosiers, Richard R ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

catenin; Epilepsy; ERK1 2 signaling pathway; GSK 3; Protein l isoaspartyl methyltransferase; RSK 1; Valproic acid

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN ISOASPARTYL METHYLTRANSFERASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; S6 KINASE; SERINE; SMALL INTERFERING RNA; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; ASTROCYTOMA; CELL LINE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SIMULATION; UPREGULATION;

ANTICONVULSANTS; ANTIMANIC AGENTS; BETA CATENIN; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHORYLATION; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION; VALPROIC ACID;

EID: 63049099412     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.01.008     Document Type: Article

References (40)

1. Boivin D., Bilodeau D., and Béliveau R. Immunochemical characterization of l-isoaspartyl-protein carboxyl methyltransferase from mammalian tissues. Biochem. J. 309 (1995) 993-998
2. Bowden C.L. Spectrum of effectiveness of valproate in neuropsychiatry. Expert Rev. Neurother. 7 (2007) 9-16
3. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., and Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 8 (2001) 1253-1264
4. Campos V.E., Du M., and Li Y. Increased seizure susceptibility and cortical malformation in β-catenin mutant mice. Biochem. Biophys. Res. Commun. 320 (2004) 606-614
5. Carriere A., Ray H., Blenis J., and Roux P.P. The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 13 (2008) 4258-4275
6. Chen W., Ji J., and Ru B. Proteomic analysis of corticobasal degeneration: a case study of corticobasal degeneration at the proteome level. J. Neuropsychiatry Clin. Neurosci. 17 (2005) 364-371
7. Dalby K.N., Morrice N., Caudwell F.B., Avruch J., and Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273 (1998) 1496-1505
8. Di Daniel E., Mudge A.W., and Maycox P.R. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. F7 (2005) 33-41
9. Ding Q., Xia W., Liu J.C., Yang J.Y., Lee D.F., Xia J., Bartholomeusz G., Li Y., Pan Y., Li Z., Bargou R.C., Qin J., Lai C.C., Tsai F.J., Tsai C.H., and Hung M.C. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol. Cell 19 (2005) 159-170
10. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23 (2003) 7311-7316
11. Fanélus I., and Desrosiers R.R. Reactive oxygen species generated by thiol-modifying phenylarsine oxide stimulate the expression of protein l-isoaspartyl methyltransferase. Biochem. Biophys. Res. Commun. 371 (2008) 203-208
12. Frödin M., and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151 (1999) 65-77
13. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24 (2004) 6590-6599
14. Ikegaya Y., Yamada M., Fukuda T., Kuroyanagi H., Shirasawa T., and Nishiyama N. Aberrant synaptic transmission in the hippocampal CA3 region and cognitive deterioration in protein-repair enzyme-deficient mice. Hippocampus 11 (2001) 287-298
15. Kalia L.V., Gingrich J.R., and Salter M.W. Src in synaptic transmission and plasticity. Oncogene 23 (2004) 8007-8016
16. Kim E., Lowenson J.D., MacLaren D.C., Clarke S., and Young S.G. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6132-6137
17. Kostrouchova M., Kostrouch Z., and Kostrouchova M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol. (Praha) 53 (2007) 37-49
18. Kuruba R., and Shetty A.K. Could hippocampal neurogenesis be a future drug target for treating temporal lobe epilepsy?. CNS Neurol. Disord. Drug Targets 6 (2007) 342-357
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
20. Lamarre M., and Desrosiers R.R. Up-regulation of protein l-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization. Neuropharmacology 55 (2008) 669-676
21. Lanthier J., and Desrosiers R.R. Protein l-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration. Exp. Cell Res. 293 (2004) 96-105
22. Lanthier J., and Desrosiers R.R. Regulation of protein l-isoaspartyl methyltransferase by cell-matrix interactions: involvement of integrin αvβ3, PI 3-kinase and the proteasome. Biochem. Cell Biol. 84 (2006) 684-694
23. Lanthier J., Bouthillier A., Lapointe M., Demeule M., Béliveau R., and Desrosiers R.R. Down-regulation of protein l-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J. Neurochem. 83 (2002) 581-591
24. Lapointe M., Lanthier J., Moumdjian R., Régina A., and Desrosiers R.R. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors. Brain Res. Mol. Brain Res. 135 (2005) 93-103
25. Lee S.M., Tole S., Grove E., and McMahon A.P. A local Wnt-3a signal is required for development of the mammalian hippocampus. Development 127 (2000) 457-467
26. Li X.N., Shu Q., Su J.M., Perlaky L., Blaney S.M., and Lau C.C. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol. Cancer Ther. 4 (2005) 1912-1922
27. Mason C.S., Springer C.J., Cooper R.G., Superti-Furga G., Marshall C.J., and Marais R. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18 (1999) 2137-2148
28. Michaelis M., Suhan T., Reinisch A., Reisenauer A., Fleckenstein C., Eikel D., Gümbel H., Doerr H.W., Nau H., and Cinatl Jr. J. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3451-3457
29. Michaelis M., Suhan T., Michaelis U.R., Beek K., Rothweiler F., Tausch L., Werz O., Eikel D., Zörnig M., Nau H., Fleming I., Doerr H.W., and Cinatl Jr. J. Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ. 13 (2006) 446-453
30. Reissner K.J., and Aswad D.W. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?. Cell. Mol. Life Sci. 60 (2003) 1281-1295
31. Robinson N.E., and Robinson A.B. Molecular Clocks: Deamidation of Asparaginyl and Glutaminyl Residues in Peptides and Proteins (2004), Althouse Press
32. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cell. Mol. Life Sci. 64 (2007) 2090-2103
33. Shen S., Elin R.J., and Soldin S.J. Characterization of cross reactivity by carbamazepine 10,11-epoxide with carbamazepine assays. Clin. Biochem. 34 (2001) 157-158
34. Shimuzu T., Matsuoka Y., and Shirasawa T. Biological significance of isoaspartate and its repair system. Biol. Pharm. Bull. 28 (2005) 1590-1596
35. Spittaels K., Van den Haute C., Van Dorpe J., Terwel D., Vandezande K., Lasrado R., Bruynseels K., Irizarry M., Verhoye M., Van Lint J., Vandenheede J.R., Ashton D., Mercken M., Loos R., Hyman B., Van der Linden A., Geerts H., and Van Leuven F. Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 4 (2002) 797-808
36. Stambolic V., and Woodgett J.R. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem. J. 303 (1994) 701-704
37. Thomas G.M., and Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5 (2004) 173-183
38. Yamamoto A., Takagi H., and Kitamura D. Deficiency in protein l-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J. Neurosci. 18 (1998) 2063-2074
39. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., and Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276 (2001) 31674-31683
40. Ziogas A., Moelling K., and Radziwill G. CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. J. Biol. Chem. 280 (2005) 24205-24211